22.626 articles found

Slow wave sleep and dopaminergic treatment in Parkinson's disease: a polysomnographic study.

Diederich NJ, Paolini V, Vaillant M.

Acta Neurol Scand · 2009-05-21

DOI: 10.1111/j.1600-0404.2009.01167.xPMID: 19485952

Levodopa-induced striatal activation in Parkinson's disease: a functional MRI study.

Kraft E, Loichinger W, Diepers M, Lule D, Schwarz J, Ludolph AC, Storch A.

Parkinsonism Relat Disord · 2009-05-20

DOI: 10.1016/j.parkreldis.2009.02.005PMID: 19467909

RAB3B FOR THE TREATMENT AND PREVENTION OF PARKINSON'S DISEASE

ISACSON OLE, CHUNG CHEE YEUN.

· 2009-05-15

RAB3B FOR THE TREATMENT AND PREVENTION OF PARKINSON'S DISEASE

ISACSON DR OLE, CHUNG CHEE YEUN.

· 2009-05-15

Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease.

Truong DD.

Clin Interv Aging · 2009-05-14

DOI: 10.2147/cia.s3787PMID: 19503773

On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?

Torta DM, Castelli L, Zibetti M, Lopiano L, Geminiani G.

Brain Cogn · 2009-05-12

DOI: 10.1016/j.bandc.2009.04.003PMID: 19442427

HMPAO SPECT in Parkinson's disease (PD) with major depression (MD) before and after antidepressant treatment.

Pålhagen SE, Ekberg S, Wålinder J, Granérus AK, Granerus G.

J Neurol · 2009-05-10

DOI: 10.1007/s00415-009-5155-xPMID: 19430931

TREATMENT FOR DISEASES RELYING ON DISCOVERY THAT THIOREDOXIN MEDIATES NITRIC OXIDE RELEASE IN CELLS

STAMLER JONATHAN S, BENHAR MORAN.

· 2009-05-07

Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide

STAMLER JONATHAN S, BENHAR MORAN.

· 2009-05-07

Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation.

Giacobbe P, Mayberg HS, Lozano AM.

Exp Neurol · 2009-05-06

DOI: 10.1016/j.expneurol.2009.04.028PMID: 19426730

Long-term retention rate of pramipexole in the treatment of Parkinson's disease.

Keränen T, Tuhkasaari M, Kuusisto H.

Eur J Clin Pharmacol · 2009-05-05

DOI: 10.1007/s00228-009-0661-4PMID: 19415250

USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS

BERGMANN JOHN E, CUTSHALL NEIL S, DEMOPULOS GREGORY A, FLORIO VINCENT A, GAITANARIS GEORGE, GRAY PATRICK, HOHMANN JOHN, ONRUST RENE, ZENG HONGKUI.

· 2009-05-04